Johnson & Johnson discovered that only 10-15% of its nearly 900 AI use cases deliver about 80% of the overall value, prompting a strategic shift to focus on the most impactful projects. Key successful applications include a generative AI assistant for sales representatives, an internal HR chatbot, and ongoing efforts in drug discovery and supply chain management using AI. This selective investment follows a period of broader experimentation as the company matured its AI strategy. Industry-wide, healthcare firms are seeing strong ROI from generative AI, with leading use cases in innovation and customer service, reflecting a larger trend of targeted AI investments for maximum impact.
Johnson & Johnson Finds Majority of AI Value Comes From Top 15% of Use Cases
- Trending
- Comments
- Latest
